Potential benefits of MOTS-c: Improved insulin sensitivity Better glucose control Increased exercise capacity Enhanced mitochondrial function Improved metabolic flexibility Unlike Semaglutide or Tirzepatide, MOTS-c does not primarily work by reducing appetite
As with any peptide therapy, proper dosage, cycle length, and medical supervision are crucial for safety
Pharmacological Reports , 2018 For more detail, read Best Forms of BPC157: Injectable vs Oral vs Capsules Explained
Research shows that transitioning within 3-10 days of the last semaglutide dose is well tolerated
Additionally, patients often opt to discontinue this medication due to issues such as intolerance, loss of insurance coverage, affordability concerns, or pharmacy shortages
Furthermore, in the study, we did not see a nadir or plateau of weight loss, so I would expect weight loss to continue if the study continued for a longer duration